ArticleACR open rheumatology2023

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype.

Benjamin Terrier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.